Surrozen Inc banner

Intrinsic Value

The intrinsic value of Surrozen Inc (SRZN) under the Base Case is 0.4 USD per share. Compared with the current market price of 29 USD, the stock appears Overvalued by 99% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SRZN Intrinsic Value
$0.4
Overvaluation 99%
Intrinsic Value
Price $29

SRZN is more expensive than usual. It was this expensive or more expensive on just 9% of days in the past 5 years.

Monitor SRZN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.32
Get notified when the price drops into your buy zone
Current Price $29
Intrinsic Value $0.4
Margin of Safety 20% $0.32
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SRZN

Fundamental Analysis

What Surrozen Does

Biotechnology Health Care

Surrozen is a biotechnology company that develops antibody-based drugs aimed at turning on the Wnt signaling pathway, a biological system that helps control tissue growth and repair. Its main goal is to create medicines that can help damaged organs and tissues regenerate, rather than just treating symptoms.

Headquarters
United States of America US
Employees
44
IPO date
Nov 23, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Surrozen Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SRZN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SRZN stock?

The intrinsic value for Surrozen Inc (SRZN) under the Base Case is 0.4 USD.

Is SRZN stock undervalued or overvalued?

Compared with the current market price of 29 USD, the stock appears Overvalued by 99% .

Back to Top